Cancer

We are advancing AI-guided diagnostic systems using multimodal data to detect various cancers earlier than traditional methods. Our platforms detect early signs of breast, colon, and lung cancers from histopathological and radiology images; and identify skin cancer from dermoscopy images.

Dengue

TVS Digital Healthcare is working on tackling a severe infectious disease called "Dengue", which is now endemic in more than 100 countries. TVS is developing an AI-guided ‘Dengue-AI’ system to identify the critical stages of Dengue patients and give the best treatment to save lives.

Pharmaceuticals

By harnessing the power of blockchain, one of our pioneering projects in the Digital Healthcare domain, the PharmaLedger project proposed new technological solutions that will improve the security of our medicines and boost trust in the pharmaceutical pipeline.

Disability Analysis

TVS is developing ‘PhyMedAI’, which uses advanced computer vision techniques to analyse and measure body poses and angles for early identification of physical disabilities.

Diabetic Retinopathy

TVS is developing ‘OphthaAI’ to diagnose diabetic retinopathy from fundus photographs using AI, which helps to prevent blindness in diabetic patients.

Federated Learning

TVS is leading the development of a federated machine learning platform for privacy-enhanced clinical data, providing a scalable AI service platform for European datasets and advancing data-driven healthcare through privacy-preserving cross-border data utilisation.

Our Solutions

Backend as a Service (BaaS)

A cloud-based platform that offers pre-built backend functionalities for developers, enabling them to create and manage healthcare applications without worrying about server infrastructure and maintenance.

IoT medical devices & personalised medicines

IoT medical devices and personalised medicines in digital healthcare leverage connected technology to monitor patient data in real time and tailor treatments to individual profiles, enhancing precision and efficiency in medical care.

Federated AI Platform

A platform designed to enable secure, privacy-preserving data analysis and collaboration in healthcare using Armoured Federated Learning, ensuring compliance with GDPR and safeguarding patient data, allowing a highly scalable service platform for users.

and many more...

Technology we use

Blockchain

TVS is driving collaborative efforts to accelerate the adoption of disruptive blockchain-based solutions in healthcare. Blockchain technology is transforming healthcare digitisation, promising significant advancements in the industry.

Distributed Storage

Medical data is stored across multiple nodes in a decentralised network. We are leveraging blockchain technology to enhance the security, privacy, and integrity of these medical data.

IoT

Through the Internet of Things (IoT) technology, we simplify the collection of distributed data from inside healthcare practices, speed up the information exchange process, and increase knowledge processing across collaborative partners.

HL7

Data is vital, but it is meaningless without proper processing. To make data meaningful, we need standardised formats adopted by health organisations. We follow the global HL7 (Healthcare Level 7) standards to facilitate this, serving as the foundation for technological advances in clinical data transfer and storage.

Federated Learning (FL)

TVS, in collaboration with research partners and hospitals across Europe, is at the forefront of developing a Federated AI service platform. This platform enables AI-powered studies of siloed, multi-site, cross-domain, and cross-border European datasets while ensuring GDPR-compliant privacy.

Differential privacy

We understand Personal Health Information (PHI) is subject to strict privacy regulations. Through this technology, we ensure patients' privacy using a transparent and immutable blockchain ecosystem.

Encrypted computation

Encrypted computation ensures that sensitive health data is protected from unauthorised access at all stages: storage, transmission, and processing; improving the overall efficiency and effectiveness of the healthcare system.

Trusted Execution Environment (TEE)

Through TEEs we securely process sensitive healthcare data, such as patient records and medical history, ensuring that this data is not exposed to unauthorised entities even if the main operating system is compromised.

Artificial Intelligence (AI)

The incorporation of Artificial Intelligence (AI) in health informatics has significantly advanced patient care through the analysis of extensive datasets, leading to improved diagnostics, personalised treatments, and predictive analytics.

Our projects

PharmaLedger

The PharmaLedger project (EU Grant Agreement no. 85399) has been successfully completed in December 2022. PharmaLedger is a blockchain-based framework for healthcare, enhancing digitalisation and patient empowerment. In this project, TVS led tasks for distributed data Integration, processing, & sharing; IoT, personalised medicine, and supply chain integrity blockchain module while promoting blockchain adoption. TVS also managed the dissemination activities of the project.

Go to Website

Consortium Partners:

TRUMPET

The TRUMPET (Trustworthy Multi-site Privacy Enhancing Technology) project (EU Grant Agreement no. 101070038 & UKRI Grant no. 10045746) aims to conduct research and develop innovative methods to enhance privacy in Federated Learning. TVS is leading the design, development, and implementation of the federated machine learning platform for privacy-enhanced clinical data in the project.

Go to Website

Consortium Partners:

FLUTE

The FLUTE (Federate Learning and Multi-party computation Techniques for prostate cancer) project (EU Grant Agreement no. 101095382 & UKRI Grant no. 10078314) aims to enhance data-driven prostate cancer care through privacy-preserving cross-border data hubs. TVS is developing the FLUTE Platform, featuring dashboards, scalability, usability, performance validation, privacy protection validation, and comprehensive documentation and user manuals.

Go to Website

Consortium Partners:

ENKORE

The ENKORE (Propelling the shift toward the future of circular, safe and sustainable packaging and single-use device solutions ecoDesigned through healthcare environments) project (EU Grant Agreement no. 101166707) aims to promote the development of new health products by integrating the principles of the Safe & Sustainable by Design (SSbD) framework, from the earliest design stages, and notably for packaging and device design including the end-of-life of a product. In the ENKORE Project, TVS will provide the ENKORE Suite of Services, where the team will design and develop cost and LCA models, circulatory calculator, ontology, and blockchain-based Digital Product Passport (DPP).